Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph Shulman currently holds 8,509 shares of RHYTHM PHARMACEUTICALS, INC. (RYTM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Shulman has been a net seller of RYTM stock. They have purchased $0 and sold $14.0M worth of shares.
Joseph Shulman's most recent insider trade was on Oct 30, 2025, when they sold 9,748 shares at $115.24 per share.
Joseph Shulman serves as Executive at RHYTHM PHARMACEUTICALS, INC. (RYTM). They have executed 69 insider transactions totaling $14.0M over their tenure at the company.
Joseph Shulman holds the position of Executive at RHYTHM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Joseph Shulman has shown a selling trading pattern, with $0 in total purchases and $14.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joseph Shulman was on Sep 2, 2025, when they sold $1.8M worth of RYTM shares. This transaction involved 16,781 shares at $105.30 per share.
Joseph Shulman currently owns 8,509 shares of RHYTHM PHARMACEUTICALS, INC. (RYTM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph Shulman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph Shulman has 69 Form 4 filings on record as an insider at RHYTHM PHARMACEUTICALS, INC..
Set alerts for Joseph Shulman and 40,000+ other insiders.